Cellectis Asset Resilience Ratio

Latest as of June 2026: 49.09%

Cellectis asset resilience ratio. Cellectis (ALCLS) has an Asset Resilience Ratio of 49.09% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Cellectis (ALCLS) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€131.26 Million

≈ $153.45 Million USD Cash + Short-term Investments

Total Assets

€267.37 Million

≈ $312.58 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Cellectis (2006–2025)

Asset resilience ratio of Cellectis from 2006 to 2025. This chart shows how Cellectis's Asset Resilience Ratio has changed over time. Read Cellectis balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Cellectis's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ALCLS total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€131.26 Million	49.09%
Total Liquid Assets	€131.26 Million	49.09%

Asset Resilience Insights

Very High Liquidity: Cellectis maintains exceptional liquid asset reserves at 49.09% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Cellectis Industry Peers by Asset Resilience Ratio

Compare Cellectis's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Immunovant Inc NASDAQ:IMVT	Biotechnology	98.50%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%

Cellectis Asset Resilience Ratio by Year (2006–2025)

Cellectis asset resilience ratio by year from 2006 to 2025. The table below shows the annual Asset Resilience Ratio data for Cellectis.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	50.12%	€162.75 Million ≈ $190.27 Million	€324.72 Million ≈ $379.63 Million	-9.17pp
2024-12-31	59.29%	€227.39 Million ≈ $265.84 Million	€383.54 Million ≈ $448.40 Million	+22.76pp
2023-12-31	36.53%	€122.11 Million ≈ $142.76 Million	€334.27 Million ≈ $390.80 Million	+29.22pp
2022-12-31	7.31%	€19.11 Million ≈ $22.34 Million	€261.22 Million ≈ $305.39 Million	-5.36pp
2021-12-31	12.67%	€48.41 Million ≈ $56.60 Million	€382.08 Million ≈ $446.69 Million	-9.41pp
2020-12-31	22.08%	€103.65 Million ≈ $121.18 Million	€469.47 Million ≈ $548.86 Million	+2.77pp
2019-12-31	19.31%	€90.28 Million ≈ $105.54 Million	€467.47 Million ≈ $546.52 Million	+8.59pp
2018-12-31	10.72%	€53.71 Million ≈ $62.79 Million	€500.84 Million ≈ $585.53 Million	-21.20pp
2016-12-31	31.93%	€105.58 Million ≈ $123.43 Million	€330.68 Million ≈ $386.60 Million	+9.94pp
2007-12-31	21.99%	€11.85 Million ≈ $13.85 Million	€53.87 Million ≈ $62.98 Million	+19.41pp
2006-12-31	2.58%	€287.00K ≈ $335.53K	€11.13 Million ≈ $13.01 Million	--

pp = percentage points

About Cellectis

PA:ALCLS France Biotechnology

Market Cap

$85.44 Million

€73.08 Million EUR

Market Cap Rank

#19558 Global

#294 in France

Share Price

€1.01

Change (1 day)

-4.10%

52-Week Range

€0.94 - €4.57

All Time High

€40.90